N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2)
-
Add time:08/26/2019 Source:sciencedirect.com
A series of 23 N-(Pyridin-3-yl)benzamides was synthesized and evaluated for their potential to inhibit human steroid-11β-hydroxylase (CYP11B1) and human aldosterone synthase (CYP11B2). The most potent and selective CYP11B2 inhibitors (IC50 values 53–166 nM) were further evaluated for their potential to inhibit human CYP17 and CYP19, and no inhibition was observed. Clear evidence was shown for N-(Pyridin-3-yl)benzamides to be a highly selective class of CYP11B2 inhibitors in vitro.
We also recommend Trading Suppliers and Manufacturers of 2-(TRIFLUOROMETHOXY)BENZAMIDE (cas 127979-74-2). Pls Click Website Link as below: cas 127979-74-2 suppliers
Prev:Synthesis of benzamide derivatives as TRPV1 antagonists
Next:Research paperDiscovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperDiscovery, structure-activity relationship studies, and anti-nociceptive effects of N-(1,2,3,4-tetrahydro-1-isoquinolinylmethyl)benzamides as novel opioid receptor agonists08/27/2019
- Synthesis of benzamide derivatives as TRPV1 antagonists08/25/2019
- The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors08/24/2019
- Original articleSynthesis and antiproliferative activity of novel 4-substituted-phenoxy-benzamide derivatives08/23/2019
- Original articleSynthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo08/22/2019
- Design, synthesis and antiproliferative activity evaluation of m-(4-morpholinyl-1,3,5-triazin-2-yl)benzamides in vitro08/21/2019
